New Release: Driving Digital Leverage for CMC Operations

HipHop Digital Leverage for CMC Operations

Television series often start to get tired as the seasons progress, but not with the QbDVision Software Release Series. As this story progresses, it only gets more exciting and each episode will keep you on the edge of your seat!

The theme of Season 8 is Digital Leverage. The best way to describe this concept is by analogy. Think about a road trip you took 15 or 20 years ago. You probably pulled out a paper map or printed some directions from a website. You checked the traffic report on your TV or radio. And, you followed the signs as you drove to get to your destination. A disconnected and reactive approach to travel.

The world is very different today. Now you enter an address on your phone and it speaks to you with step-by-step directions to get there with layered in traffic data and building/landmarks in order to get there efficiently and find that fast-food meal you are craving at the end of a long day of driving.

 

How did this happen? Satellites digitized the earth with multiple layers of structured data and then added in more layers of information like cell phone tracking. These layers of structured data were then combined together to give you the integrated value that comes with digitized maps. This is Digital Leverage.

QbDVision is doing the exact same thing for CMC operations over the development lifecycle and this release of QbDVision, entitled Hip Hop, brings even more digital leverage to your CMC operations.

Here’s a snapshot of this season’s episode lineup

NEW FEATURE

Episode 1: Digital Control Strategy

NEW FEATURE

Episode 2: The Evolution of Acceptance Criteria

NEW FEATURE

Episode 3: I Want To Be Dynamic

NEW FEATURE

Episode 4: You Are Out Of Order!

Updated Feature

Episode 5: The Document Connection

Updated Feature

Episode 6: Don’t Forget The Small Stuff

Updated Feature

Season Finale: Integration Management (What is that?)

Grab your popcorn (don’t forget the butter) and let’s get started!

NEW FEATURE

Episode 1: Digital Control Strategy

The development of new therapies is a complex process that requires the convergence of multiple workstreams to tell a story about control. While regulators are very focused on the safety and efficacy of these therapies, they are equally focused on product quality. Product quality is a function of how the manufacturing process and production facilities are controlled to produce the drug substance and drug product per the specifications and regulatory requirements (see ICH Q8(R2) Section II.E). 

QbDVision uses the digital leverage concept to simplify the development of a systematic control strategy. New features include:

  • Tagging product and process variables how they will be controlled (e.g. Release Testing, Monitoring, Characterization, In-Process Testing, and more!).
  • Tagging quality attributes to identify which are stability-indicating.
  • Scoping final quality attributes to  Drug Substance or Drug Product (DS/DP).
  • New reports for Product Quality Attributes, Product Release Specifications, and Product Stability Testing Panel.
  • Categorizing Control Methods as Analytical Methods, Monitoring, PAT, SOP/Training, and Facility Class.
  • Linking Materials and Control Methods to multiple compendial standards.
  • Merging Drug Substance and Drug Product categories for Materials and adding more specific categories for a better description. 
  • Automating Control Strategy Reporting: 
    • Product Quality Attributes
    • Product Release Specifications
    • Product Stability Testing
    • In-Process Quality Attributes
    • Characterization Testing Reports
    • Process Parameter Control Strategies
    • Material Attribute Control Strategies

Wow! How much time will this save you managing this information manually? That’s the beauty of digital leverage when applied to CMC. Our next release will build on this structure to enable broader visualization and reporting to enable a systematic approach to the definition, justification, and communication of the overall control strategy.

NEW FEATURE

Episode 2: The Evolution of Acceptance Criteria

As the team moves through their development stages, they’re gaining a richer understanding of their product and process by assessing prior knowledge, doing in vitro studies, and executing process characterization. We have added new capabilities to dynamically manage acceptance criteria.  

  • Product Ranges – set up submission ranges, in vitro, animal studies, ranges from prior knowledge, and more for CQAs.
  • Process Ranges – set up NOR (normal operating range), PAR (proven operating range – ICH Q8 R2), validation ranges, and more for CPPs and CMAs.
  • Grouping Criteria – Acceptance criteria groups allow users to logically arrange similar ranges, for example, separate product acceptance criteria for US and EU submissions
NEW FEATURE

Episode 3: I Want To Be Dynamic

Don’t we all!  Who wants to be static?  That’s no fun!  Initially launched with our tech transfer functionality, we’ve expanded the representation of information in dynamic tabular views. We have extended the concept of the dynamic table to all the information in the Product and Process layers for any project. Now, you can create custom views and exports of all your product and process information. Whoa!

Functionality in the dynamic table view includes:

  • Excel-like Power in your browser. Select columns, sort, and filter your information so you can customize your views and see what matters to you most.
  • Shareable views. Once you have set up your table to focus on the information that matters, share the specific URL with coworkers to see the same view.
  • Smart exports. Export what you see on the screen and take it with you, including your filters and sorting.
NEW FEATURE

Episode 4: You Are Out Of Order!

It’s time for the most anticipated episode of the series. Our Process Explorer module tackles its most popular request: Defining order for process parameters.

QbDVision is the first vertically integrated knowledge management system for pharma and biotech – bringing definition, risk, control, and analytics into one platform. Until now, when defining process parameters, the system didn’t specify the order of those parameters. Instead, it focused on grouping them with related components or materials in our knowledge graph. This grouping provided a contextual link that was important for thinking about your product and process. However, we recognized that process parameters have a natural order to them. 

In our previous release, we introduced a new feature, Steps, to our Unit Operations. Steps provide a foundation for creating process order by providing a lower-level structure of the actions that take place in a process. 

Now, we have added the ability to explicitly define the order of those process parameters inside their Unit Operations or Steps. Using a simple drag and drop interface, you can specify the order in which parameters occur within your process. This is, of course, in addition to linking them to the components and materials, as well as their downstream risks.

This capability brings us one step closer to defining the final recipe within QbDVision in alignment with the ISA88 process definitions which can subsequently be transferred to your manufacturing execution system (MES).

Updated Feature

Episode 5: The Document Connection

Whether you’re executing a product or process risk assessment, justifying your assessments is an important part of the workflow. Literature references, historical product knowledge, clinical information, DoEs, etc., are all part of a robust justification. Our source document widget allows users to attach or link to information – documents and reports stored in an eQMS, reports or analytics in a different system, or even other projects on our platform. 

Linking this information not only provides a robust justification that is the basis for final submission, but also helps users understand and learn from prior knowledge. QbDVision serves as a single point of reference to multiple sources and workstreams. It helps bring together the big picture.

In this release, we’ve expanded this linking capability such that you can assign multiple source documents to their criticality assessments in final quality attributes using risk ranking and in our process parameters records.

Updated Feature

Episode 6: Don’t Forget The Small Stuff

We all know the devil is in the details and Season 8 highlights the combination of many customer-driven improvements and new robust capabilities for product and process management. We are big believers in making sure our customers are happy and there is no better way to do that than to show them we are listening. You can always make a feature request through our customer support portal and we wanted to highlight some of the changes to the QbDVision platform that were requested by our loyal users.

Here are a few worth mentioning:

  • Case insensitive imports – Uploading data into the platform just got a little easier with fewer restrictions on the upload process.
  • Additional to supplier tracking, including additional comment fields and better tracking of virtual audits.
  • New fields tracking the status of calibration development and tracking of a “Design Qualification (DQ)” state for Process Components.
  • Additional project definitions for ‘Phase 2a’ and ‘Phase 2b’.
  • Support for new Document Types in our QMS module including CAPA, Change Request, and Non-Conformance/Deviation
Updated Feature

Season Finale: Improved Integration Management

Season 8 ends with the appearance of the “Consultants” with some serious consultant “speak”.  As the contextual layers of your product, process, and control strategy come together in QbDVision, it’s important that data and information are able to flow into and out of our system. Advanced users of our platform with technical capabilities can use our REST API infrastructure to programmatically access the information within QbDVision.

We’ve extended this capability to include: 

  • A user interface for generating API keys and managing their associated permissions
  • Better online documentation for the API itself
  • An Open API 3.0 compliant specification.

As we tease Season 9, we’re continuing to invest significantly in our product development in light of our recent funding announcement

If you are new to QbDVision and are interested in trying out our solution, please reach out to learn more about exploring the platform’s expanded capabilities.

Mark Fish

Managing Director, Scientific Informatics, Accenture

Mark Fish is Managing Director and Global Lead for Accenture’s Scientific Informatics Services Business. Mark has over 25 years of experience in leadership roles in Accenture, Brooks Life Sciences and Thermo Fisher Scientific delivering innovative solutions to the pharmaceutical sector and is passionate about drug discovery and development, translation research and manufacturing transformation. Mark has extensive experience in agile software development, data strategy, process engineering and robotic automation for research, analytical development and quality control in Life Sciences.

Chris Puzzo

Solution Architect, Digital & Data, Zaether

Chris is a Solution Architect with Zaether, focusing on delivering next-generation digital and data solutions for GxP Life Sciences customers. Chris has previously held technical operations roles within multiple gene therapy manufacturers, including Thermo Fisher Scientific’s CDMO organization where he supported various capital projects including the design, build, and startup of new GxP manufacturing capacity.

Victor Goetz, Ph.D

Executive Director, TS/MS New Modalities and Data Strategy, Eli Lilly and Company

Victor Goetz, Ph.D. is the Executive Director of Technical Services New Modalities and Data Strategy at Eli Lilly and Company. He has over 35 years of industry experience in developing and commercializing nine novel medicines to enhance the exchange of knowledge needed to speed the delivery of new medicines to patients. Dr. Goetz holds a BS in chemical engineering from Stanford University and a PhD in chemical and biochemical engineering from the University of Pennsylvania.

Rachelle Howard

Director of Manufacturing Systems Automation and Digital Strategy, Vertex Pharmaceuticals

Rachelle is the Director of Manufacturing Systems Automation and Digital Strategy for Vertex’s Small Molecule Manufacturing Center. She oversees the site Automation Engineering function and has co-led Vertex’s global Digital Manufacturing Transformation program since 2019. She leads several initiatives related to data integrity, data management, and employee education. Rachelle is a graduate of Tufts University and the University of Connecticut where she has degrees in Chemical Engineering and a PhD in Process Control.

Vijay Raju

Vice President, CMC Management, Flagship Pioneering

Vijay currently leads CMC activities to deliver on Pioneering Medicines portfolio. The portfolio is built on Flagship Pioneering’s bio-platforms covering multiple modalities (small molecules, biologics, cell & gene therapies). Vijay was previously in technical leadership roles at Novartis.

Greg Troiano

Head of cGMP Strategic Supply & Operations, mRNA Center of Excellence, Sanofi

Greg serves as Head of cGMP Strategic Supply and Operations at the mRNA Center of Excellence at Sanofi, where he is responsible for all aspects of clinical production and raw material supply chain. He joined Sanofi via acquisition of Translate Bio, where he was Chief Manufacturing Officer and responsible for Technical Operations. Over his 20+ year career in the drug delivery field, Greg had various roles leading the pharmaceutical development of complex formulations, including numerous nano- and microparticle based systems. Greg received his MSE and BS in Biomedical Engineering from The Johns Hopkins University and was elected and inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2020 for recognition of his accomplishments in drug delivery.

Pat Sacco

Senior Vice President Manufacturing, Quality, and Operations, SalioGen

Pat is a Biotechnology technical operations executive with 30+ years of experience leading and managing technical operations functions at numerous innovative companies in the biotech and life sciences industries. He has a passion for advancing and implementing best practices in pharmaceutical manufacturing.

Diana Bowley

Associate Director, Data & Digital Strategy, AbbVie

Diana is the Associate Director, Data & Digital Strategy in S&T-Biologics Development and Launch leading the organization’s Digital Transformation since October 2021. She joined AbbVie in 2012 in the R&D-Discovery Biologics group focused on antibody and multi-specific protein screening and engineering, leading multiple programs to the cell line development stage. In 2017 she joined Information Research and led a team of IT professionals who supported AbbVie’s Discovery Scientists in Biotherapeutics, Chemistry, Immunology and Neuroscience. She has a PhD in Molecular Biology from The Scripps Research Institute and Bachelor of Science in Chemistry from The University of Northern Iowa.

Robert Dimitri, M.S., M.B.A.

Director Digital Quality Systems, Thermo Fisher Scientific

Robert Dimitri is a Director of Digital Quality Systems in Thermofisher’s Pharma Services Group. Previously he was a Digital Transformation and Innovation Lead in Takeda’s Business Excellence for the Biologics Operating Unit while leading Digital and Data Sciences groups in Manufacturing Sciences at Takeda’s Massachusetts Biologics Site.

Devendra Deshmukh

Global Head, Digital Science Business Operations, Thermo Fisher Scientific

Devendra Deshmukh currently leads Global Business Operations for Digital Science Solutions at Thermo Fisher Scientific. In this role he oversees operations broadly for the business across its product portfolio and leads the global professional services, technical support, and product education teams.

Grant Henderson

Sr. Dir. Manufacturing Science and Technology, VernalBio

Grant Henderson is the Senior Director of Manufacturing Science and Technology at Vernal Biosciences. He has years of expertise in pharmaceutical manufacturing process development/characterization, advanced design of experiments, and principles of operational excellence.

Ryan Nielsen

Life Sciences Global Sales Director, Rockwell Automation

Ryan Nielsen is the Life Sciences Global Sales Director at Rockwell Automation. He has over 17 years of industry experience and a passion for collaboration in solving complex problems and adding value to the life sciences space.

Shameek Ray

Head of Quality Manufacturing Informatics, Zifo

Shameek Ray is the Head of Quality Manufacturing Informatics and Zifo and has extensive experience in implementing laboratory informatics and automation for life sciences, forensics, consumer goods, chemicals, food and beverage, and crop science industries. With his background in services, consulting, and product management, he has helped numerous labs embark on their digital transformation journey.

Max Peterson​

Lab Data Automation Practice Manager, Zifo

Max Petersen is the Lab Data Automation Practice Manager at Zifo responsible for developing strategy for their Lab Data Automation Solution (LDAS) offerings. He has over 20 years of experience in informatics and simulation technologies in life sciences, chemicals, and materials applications.

Michael Stapleton

Board Director, QbDVision

Michael Stapleton is a life sciences leader with success spanning leadership roles in software, consumables, instruments, services, consulting, and pharmaceuticals. He is a constant innovator, optimist, influencer, and digital thought leader identifying the next strategic challenge in life sciences, executing and operationalizing on high impact strategic plans to drive growth.

Matthew Schulze

Head of Digital Pioneering Medicines & Regulatory Systems, Flagship Pioneering

Matt Schulze is a Senior Director in the Flagship Digital, IT, and Informatics team, where he leads and manages the digital evolution for Pioneering Medicines. His role is pivotal in ensuring that digital strategies align with the overall goals and objectives of the Flagship Pioneering initiative.

His robust background in digital life sciences includes expertise in applications, informatics, data management, and IT/OT management. He previously spearheaded Digital Biomanufacturing Applications at Resilience, a CDMO start-up backed by Arch, where he established a team responsible for implementing global manufacturing automation systems, Quality Assurance applications, laboratory systems, and data management applications.

Matt holds a B.S. in Biology and Biotechnology from Worcester Polytechnic Institute and an M.B.A. from the Boston University Questrom School of Business, where he focused on Strategy and Innovation.

Daniel R. Matlis

Founder and President, Axendia

Daniel R. Matlis is the Founder and President of Axendia, an analyst firm providing trusted advice to life science executives on business, technology, and regulatory issues. He has three decades of industry experience spanning all life science and is an active contributor to FDA’s Case for Quality Initiative. Dan is also a member of the FDA’s advisory council on modeling, simulation, and in-silico clinical trials and co-chaired the Product Quality Outcomes Analytics initiative with agency officials.

Kir Henrici

CEO, The Henrici Group

Kir is a life science consultant working domestically and internationally for over 12 years in support of quality and compliance for pharma and biotech. Her deep belief in adopting digital technology and data analytics as the foundation for business excellence and life science innovation has made her a key member of PDA and ISPE – she currently serves on the PDA Regulatory Affairs/Quality Advisory Board

Oliver Hesse

VP & Head of Biotech Data Science & Digitalization, Bayer Pharmaceuticals

Oliver Hesse is the current VP & Head of Biotech Data Science & Digitalization for Bayer, based in Berkeley, California. He has a degree in Biotechnology from TU Berlin and started his career in a Biotech start-up in Germany before joining Bayer in 2008 to work on automation, digitalization, and the application of data science in the biopharmaceutical industry.

John Maguire

Director of Manufacturing Sciences, Sanofi mRNA Center of Excellence

With over 18 years of process engineering experience, John is an expert in the application of process engineering and operational technology in support of the production of life science therapeutics. His work includes plant capability analysis, functional specification development, and the start-up of drug substance manufacturing facilities in Ireland and the United States.

Chris Kopinski

Business Development Executive, Life Sciences and Healthcare at AWS

As a Business Development Executive at Amazon Web Services, Chris leads teams focused on tackling customer problems through digital transformation. This experience includes leading business process intelligence and data science programs within the global technology organizations and improving outcomes through data-driven development practices.

Tim Adkins

Digital Life Science Operations, ZÆTHER

Tim Adkins is a Director of Digital Life Sciences Operations at ZÆTHER, serving the life science industry by assisting companies reach their desired business outcomes through digital IT/OT solutions. He has 30 years of industry experience as an IT/OT leader in global operational improvements and support, manufacturing system design, and implementation programs.

Blake Hotz

Manufacturing Sciences Data Manager, Sanofi

At Sanofi’s mRNA Center of Excellence, Blake Hotz focuses on developing data ingestion and cleaning workflows using digital tools. He has over 5 years of experience in biotech and holds degrees in Chemical Engineering (B.S.) and Biomedical Engineering (M.S.) from Tufts University.

Anthony DeBiase

Offering Manager, Rockwell Automation

Anthony has over 14 years of experience in the life science industry focusing on process development, operational technology (OT) implementation, technology transfer, CMC and cGMP manufacturing in biologics, cell therapies, and regenerative medicine.

Andy Zheng

Data Solution Architect, ZÆTHER

Andy Zheng is a Data Solution Architect at ZÆTHER who strives to grow and develop cutting-edge solutions in industrial automation and life science. His years of experience within the software automation field focused on bringing innovative solutions to customers which improve process efficiency.

Sue Plant

Phorum Director, Regulatory CMC, Biophorum

Sue Plant is the Phorum Director of Regulatory CMC at BioPhorum, a leading network of biopharmaceutical organizations that aims to connect, collaborate, and accelerate innovation. With over 20 years of experience in life sciences, regulatory, and technology, she focuses on improving access to medicines through innovation in the regulatory ecosystem.

Yash Sabharwal​

President & CEO, QbDVision

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started 3 companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.

Joschka Buyel

Senior MSAT Scientist at Viralgen, Process and Knowledge Management Scientist at Bayer AG

Joschka is responsible for the rollout and integration of QbDVision at Bayer Pharmaceuticals. He previously worked on various late-stage projects as a Quality-by-Design Expert for Product & Process Characterization, Process Validation, and Transfers. Joschka has a Ph.D. in Drug Sciences from Bonn University and a M.S. and B.S. in Molecular and Applied Biotechnology from the RWTH University.

Luke Guerrero

COO, QbDVision

A veteran technologist and company leader with a global CV, Luke currently oversees the core business operations across QbDVision and its teams. Before joining QbDVision, he developed, grew, and led key practices for international agency Brand Networks, and spent six years deploying technology and business strategies for PricewaterhouseCoopers’ CIO Advisory consulting unit.

Gloria Gadea Lopez

Head of Global Consultancy, Business Platforms | Ph.D., Biosystems Engineering

Gloria Gadea-Lopez is the Head of Global Consultancy at Business Platforms. Using her prior extensive experience in the biopharmaceutical industry, she supports companies in developing strategies and delivering digital systems for successful operations. She holds degrees in Chemical Engineering, Food Science (M.S.), and Biosystems Engineering (Ph.D.)

Speaker Name

Speaker’s Pretty Long Title, Specialty, and Business

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam dignissim velit et est ultricies, a commodo mauris interdum. Etiam sed ante mi. Aliquam vestibulum faucibus nisi vel lacinia. Nam suscipit felis sed erat varius mollis. Mauris diam diam, viverra nec dolor et, sodales volutpat nulla. Nam in euismod orci.